Investor
Every published round Aura Private Equity took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
Companies Aura Private Equity has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| No portfolio companies recorded yet. | ||||
Fund closes reported for Aura Private Equity, as distinct from the investments it has made.
Companies Aura Private Equity has backed that another company then bought. An exit for the holding, not a deal Aura Private Equity did.
| Name | Role | Sources |
|---|---|---|
| Andrew Nai | Director | Aura Group portfolio |
Stories naming Aura Private Equity. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Aura Private Equity has backed Australia Vaccine Services in finishing its purchase of Medimobile, a corporate workplace flu-vaccination provider, uniting two immunisation operators nationwide. No deal price was disclosed.
Aura's private equity arm announced a follow-on investment in Kim Health Care's US$24 million Series B, led by Singapore's ABC World Asia, backing the Vietnamese dental clinic chain Kim Dental and its laboratory Labo.